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Multidrug-resistant organisms (MDROs) such as multidrug-resistant (MDR) Acinetobacter baumannii and 
Escherichia coli are important pathogens associated with nosocomial infections in both human and animal health care 
facilities. Surfaces of inanimate objects in health care facilities can serve as sources of infection. However, studies on 
prevalence of these pathogens in veterinary settings are lacking in the country. Therefore, the objectives of this study 
were to determine the occurrence of A. baumannii and E. coli and the occurrence of MDR isolates on surfaces of 
inanimate objects in veterinary health care facilities in Klang Valley, Malaysia. In this study, swab samples were taken 
from 65 surfaces of inanimate objects that included door knobs, examination tables, labcoats, stethoscopes and 
weighing scales. The swab samples were cultured and all isolates were subjected to antibiotic susceptibility test. The 
study revealed that the occurrence of A. baumannii was 9.23% and 5 out of 6 (83.33%) A. baumannii isolates were 
classified as MDR. However, no E. coli was isolated.  In conclusion, surfaces of inanimate objects can be a source of 
MDR A. baumannii in veterinary health care facilities that is of animal and public health concern. 
 





Multidrug-resistant organisms (MDRO) are often 
involved in hospital associated infection (HAI). Bacteria 
isolates that acquired non-susceptibility to at least one 
agent in three or more antimicrobial categories are 
classified as MDR (Magiorakos et al., 2012). As defined 
by its name, MDROs limits options treatment and may 
worsen prognosis of patients.  
Over the last decade, Acinetobacter baumannii have 
emerged as a significant opportunistic nosocomial 
pathogen. Acinetobacter baumannii is a gram negative 
bacteria which belongs to the family of Moraxellaceae. 
The name “Acinetobacter” originates from a Greek word 
“akinetos” which means unable to move (Doughari et al., 
2011). It is strictly aerobic, non-motile, catalase-positive, 
indole-negative, oxidase-negative, non-fermentative 
encapsulated coccobacilli (Singh et al., 2013).  
According to Centers for Disease Control and 
Prevention (CDC) there are many species of 
Acinetobacter spp. and all can cause disease. However, 
Acinetobacter baumannii accounts about 80% of reported 
infections in humans (CDC, 2010). Peleg et al. (2008) 
stated that A. baumannii can cause pneumonia, 
bloodstream infection and occasionally skin infection, 
urinary tract infection (UTI), meningitis and soft tissue 
infection in humans. In animals, A baumannii were 
isolated from those suffering from UTI, pyothorax, upper 
airway obstruction, bloodstream infection and wound 
infection (Francey et al., 2000).  
In a six years study following 505 animal patients 
with nosocomial bacteraemia, Jerassy et al. (2006)  
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concluded that in-hospital mortality in those with A. 
baumannii bacteraemia (57%) was significantly higher 
than bacteraemia cause by other gram negative organism 
(31-43%).  
Acinetobacter baumannii can be found ubiquitously 
especially in soil, water, animals and humans (Baumann, 
1968; Fournier & Richet, 2006). Acinetobacter baumannii 
is an opportunistic pathogen. Therefore, infections caused 
by this pathogen are usually found in patients that are ill 
or immunosuppressed.  
The ability of an organism to survive on dry surface 
is important to determine if surfaces of inanimate objects 
can be a source of infection especially in health care 
settings. A study conducted in 1998 showed that the 
survival times of sporadic strains of A. baumannii is 27.2 
days and outbreak strains survives for 26.5 days on dry 
surfaces. However, the survival time for both strains was 
not statistically different (Jawad et al., 1998). In Malaysia, 
MDR A. baumannii are common isolates from intensive 
care unit of human hospital (Kong, 2011; Lean et al., 
2014). However, such studies were not done in veterinary 
patients and environment of veterinary facilities of 
Malaysia. 
Nosocomial A. baumannii isolates are mostly 
multidrug resistant and antimicrobial susceptibility test 
showed that outbreak strains were significantly more 
resistant to various broad-spectrum antimicrobial agents 
than sporadic strains (Jawad et al., 1998). Apart from that, 
extensive drug resistant (XDR) A. baumannii which are 
resistant to all but one or two classes of antibiotics and 
even pandrug resistant (PDR) isolates that are resistant to 
all classes of antibiotics are emerging at an alarming rate. 
A study using strains isolated from a main tertiary hospital 
in Terengganu showed that out of the 54 isolates, 39 
(72.2%) were multidrug resistant (MDR) and resistant to 
carbapenems whereas 14 (25.9%) were categorised as 




extensive drug resistant (XDR) with additional resistance 
to polymyxin B, the drug of “last resort” (Lean et al., 
2014). 
Escherichia coli is a gram negative, facultative 
anaerobic, non-spore-forming, motile rod which belongs 
to the family Enterobacteriaceae. The genus was named 
after Theodor Escherich, the person who first isolated E. 
coli in 1884 (Schaechter and Lederberg, 2004). 
The pathogenic E. coli are classified into 
extraintestinal (ExPEC) or intestinal pathogenic E. coli 
(InPEC) based upon the anatomical site in which diseases 
occur.  
ExPEC strains usually cause infections outside of 
the intestinal tract such as urinary tract infections, 
neonatal meningitis and septicaemia. E. coli are the most 
common etiological agent that cause UTI in humans, cats 
and dogs (Seguin et al., 2003; Litster et al., 2009; Farajnia 
et al., 2009). However, they have the ability to colonize 
the intestinal tract without causing disease. In contrast, 
intestinal colonization by InPEC strains can cause 
different types of gastroenteritis with different infection 
mechanisms and symptoms (Nataro, 2004). 
Most studies show that after the introduction of an 
antibiotic, not only the level of resistance of pathogenic 
bacteria, but also of commensal bacteria increases. This is 
of concern as commensal bacteria can serve as a reservoir 
of resistance genes for pathogenic bacteria. Therefore, 
apart from monitoring the prevalence of resistance in 
indicator bacteria such as faecal E. coli and enterococci in 
humans and animals it also allow us to detect transfer of 
resistant bacteria or resistance genes from animals to 
humans and vice versa (Bogaard and Stobbeingringh, 
2000). 
Antibiotic resistance of most MDROs are often seen 
in commonly used antibiotics. In a retrospective study 
conducted by Kibret and Abera (2011) by using clinical 
source of E. coli in northeast Ethiopia, high resistance 
rates to erythromycin (89.4%), amoxicillin (86.0%) and 
tetracycline (72.6%) were documented. However, there 
were significantly high degree of sensitivity rates towards 
nitrofurantoin (96.4%), norflaxocin (90.6%), gentamicin 
(79.6%) and ciprofloxacin. In dogs and cats, resistance 
was  
In dogs and cats, resistance was observed towards 
streptomycin (96.4%), neomycin (85.1%), amoxicillin 
(70.2%), and gentamicin (68.1%) (Magdalena et al., 
2015). Furthermore, the percentage of MDR isolates had 
been increasing at an alarming rate in clinical isolates of 
cats and dogs from 50.0% in 2007-2008 to 89.9% in 2013 
(Magdalena et al., 2015). 
Apart from all the above, Malaysia lacks 
information regarding the prevalence of these two MDR 
bacteria especially in veterinary health care settings. 
Therefore, the objectives of this study were to determine 
the prevalence of A. baumannii and E.coli on surfaces of 
inanimate objects in veterinary facilities and to determine 
the multidrug-resistance of the isolates. 
 




Swabs of 65 surfaces of inanimate objects in four 
veterinary health care facilities of Klang Valley were 
taken. Types of inanimate objects and sampling site of 
each object are summarized in Table 1. Sterile swabs pre-
moistened with phosphate buffered saline (PBS) were 
used. 
 
Bacterial isolation and identification 
 
Samples were cultured on MacConkey agar (Oxoid) 
for isolation of A. baumannii and Chromocult® Coliform 
Agar (CCA) for isolation of E. coli and incubated 
overnight at 37oC. All gram negative bacteria that grew on 
MacConkey and CCA agar were subcultured after gram 
staining for 24 hr at 37oC. For identification of E. coli, a 
drop of KOVACS’ reagent was placed directly on dark 
purple colonies on CCA. Colonies of E. coli would turn 
cherry red within seconds. All other gram negative 
colonies were subjected to biochemical tests as described 
by Jang et al. (2008) such as triple sugar iron agar (TSI), 
sulfa-indole motility test (SIM), citrate, and urease test. 
Suspected A. baumannii which matched all biochemical 
results were further grown at 41oC and 44oC. The 
identified Acinetobacter spp. were further confirmed up to 
genus level by using RapIDTM NF Plus System (Thermo 
Scientific). RapIDTM NF Plus System is an identification 
kit based on enzyme technology. It consisted of a clear 
plastic tray which contained 10 reagent impregnated 
wells. A suspension of test organism in RapID 
Innoculation Fluid was used as the inoculum which 
rehydrated and initiated test reactions. Other gram 
negative bacteria such as Pseudomonas aeruginosa, 
Alcaligenes faecalis, and Moraxella sp. were also tested 
by using RapIDTM NF Plus. 
 
Table 1. List of inanimate objects and the area where swabs samples were taken 
 
Types of inanimate objects 
 





Door handles 18 Whole surface 
Examination tables 18 100cm3 at the center of the table top 
Labcoats 9 3 cm wide at the posterior end of sleeves and 100cm3 at 
the abdomen above the level of navel. 
Stethoscopes 9 Bell and diaphragm 
Weighing scales 9 100cm3 at the center of the weighing platform 
Animal cage 2 100cm3 at the center of cage floor 




Antibiotic susceptibility test 
 
The antibiotic susceptibility test using disk diffusion 
method was performed on all isolates. The antibiotic 
agents, concentration of the antibiotic disk used and the 
antibiotic susceptibility interpretative criteria are 
summarized in Table 2. 
Bacteria isolates that acquired non-susceptibility to 
at least one agent in three or more antimicrobial categories 




Out of 65 samples obtained, 16 samples (24.62%) 
were positive for gram negative bacteria with a total of 22 
isolates. Six samples (9.23%) were positive for A. 
baumannii. Among the gram negative bacteria, A. 
baumannii contributed 27.27%, Achromobacter sp. 
contributed 22.72%, Acinetobacter lowffii contributed 
9.10%, Enterobacter aerogenes contributed 9.10%, 
Acinetobacter calcoaceticus, Pseudomonas aeruginosa, 
Alcaligenes faecalis, Bordetella sp., Moraxella sp., Hafnia 
alvei  and Chromobacter sp. contributed 4.55% each 
(Table 3). From Table 4, most A. baumannii isolates were 
found in facility 1, 2 and 3 and was most commonly 
isolated from stethoscopes (22.2%). 
 
 
Table 2. Antibiotic Susceptibility Interpretative 
Criteria as described by CLSI VET01-S2 guideline 
(2013) 
 
Antimicrobial agent Disk 
content 
Zone diameter (mm) 
 S    I  R 
Amoxicillin/ 
clavulanic acid* 
30µg ≥18 14-17 ≤13 
Enrofloxacin 5µg ≥23 17-22 ≤16 
Tetracycline*  30µg ≥15 12-14 ≤11 
Cephalexin* 30µg ≥18 15-17 ≤14 
Sulphamethoxazole/ 
Trimethoprim* 
25µg ≥16 11-15 ≤10 
 
^S, susceptible; I, intermediate susceptibility; R, resistant 
*Human-derived zone diameter interpretative standards 
 
Table 3: Gram negative bacteria isolated from different surfaces 
Types of inanimate objects (No. of surfaces sampled) Gram negative bacteria isolated Number of isolates












Examination tables (18) Achromobacter sp. 2 






Stethoscopes (9) Acinetobacter baumannii 3 








Animal cages (2) Chromobacter sp. 1 
        Total  22 
 




1 2 3 4 Total 
Door handles 1/12 1/2 1/2 0/2 3/18(16.7%) 
Examination tables 0/12 0/2 0/2 0/2 0/18     (0%) 
Labcoats 0/6 0/1 1/1 0/1 1/9  (11.1%) 
Weighing scales 0/6 0/6 0/6 0/6 0/9       (0%) 
Stethoscopes 2/6 0/1 0/1 0/1 2/9  (22.2%) 
Animal cages 0/2 na na na 0/2       (0%) 
Total 3/44 (6.1%) 1/12 (8.3%) 2/12 (16.7%) 0/12 (0%) 6/65 (9.2%) 
            na – not available




Antibiotic susceptibility test revealed that 15 out of 
22 isolates (68.18%) were classified as MDROs, that is, 
they were resistant towards to at least one agent in three or 
more antimicrobial categories. Most isolates were 
resistant towards cephalexin (95.45%), followed by 
enrofloxacin (59.09%), amoxicillin-clavulanic acid 
(54.55%), sulphamethoxazole-trimethoprim (54.55%) and 
tetracycline (50%). 
Five out of six A. baumannii isolates (83.33%) were 
classified as MDR after subjected to antibiotic 
susceptibility test (Table 3). Figure 3 shows an 
Acinetobacter baumannii isolate showing resistance to all 
antibiotics tested. From the antibiotic susceptibility 
profile, all six (100%) A. baumannii isolates were 
resistant to cephalexin, all isolates except for one 
(83.33%) were resistant to tetracycline and enrofloxacin, 
three isolates (50%) were resistant towards amoxicillin-





The study showed that six samples (9.23%) were 
positive for A. baumannii while none of the samples was 
positive for E. coli. This imposes that surfaces of 
inanimate objects can be a source of A. baumannii for 
both human and animals. In this study, A. baumannii were 
identified by using biochemical test and further confirmed 
up to genus level by using RapIDTM NF Plus identification 
system. According to a study done by Kitch et al. (1992), 
RapIDTM NF Plus provides an accurate commercial non-
automated method which correctly identified 311 strains 
out of 345 strains (90.1%) without additional tests. The 
detection of A. baumannii by using molecular method is 
confirmatory but it is more time consuming. 
From the result, no E. coli were isolated. The 
possible reasons for not acquiring any E. coli isolates 
could be due to low prevalence of E. coli itself on surfaces 
swabbed. Apart from that, according to Elsas et al. (2011), 
when E. coli are adapted to a niche, they lose the ability to 
adapt in another. Due to this, enteric E. coli that are 
passed out to the environment may not survive for long. 
Besides that, using sterile gauze pad of a fixed size a 
larger surface area and enriched in brilliant green bile 2% 
may increase the likelihood of recovering E. coli 
(Barkocy-Gallagher et al., 2002). 
In this study, antibiotic susceptibility test revealed 
that 15 out of 22 isolates (68.18%) were classified as 
MDROs. Most isolates were resistant towards cephalexin 
(95.45%), followed by enrofloxacin (59.09%), 
amoxicillin-clavulanic acid (54.55%), sulphamethoxazole-
trimethoprim (54.55%) and tetracycline (50%). From the 
result, we know that the occurrence of multidrug resistant 
gram negative isolates is quite high which is similar to a 
study done with human clinical isolates in Assam, India 
with 50.6% classified as MDR (Dutta et al., 2014). 
Cephalexin is a first generation cephalosporin that is 
active against many gram-positive bacteria and a range of 
gram-negative bacteria (Bailey et al, 1970). However, its 
resistance among gram negative bacteria is widespread 
and are rarely recommended for serious gram negative 
infections (CDC, 2013). Enrofloxacin, amoxicillin-
clavulanic acid, sulphamethoxazole-trimethoprim and 
tetracycline are all broad spectrum antibiotics that are 
commonly used in small animal practice and are active 
against both gram positive and gram negative bacteria. 
Therefore, resistance of these gram negative isolates 
against drugs mentioned above are significantly alarming. 
It is recommended that antibiotic susceptibility test should 
be performed to ensure effective antimicrobial therapy 
especially in cases of hospital acquired infection. 
The study showed high occurrence of MDR A. 
baumannii and all six (100%) were resistant to 
cephalexin. This is similar with a study in Iran with 97% 
resistant against cephalexin and 65% were resistant to 
tetracycline. Highest resistance was demonstrated on beta-
lactams antibiotic including cephalosporins (Aliakbarzade 
et al., 2014). For treatment of infections caused by A. 
baumannii, polymyxin B and colistin are considered as 
the last resort (Zavascki et al., 2007). The ability to 
acquire resistance determinants easily has made this 
bacteria to be one of the most troublesome nosocomial 
pathogen. In a study with 97 clinical isolates, 80% of the 
isolates were found to be MDR and each strain harboured 
between one and 17 resistant determinants. A total of 52 
unique resistance determinants or gene families were 
detected which are known to confer resistance to β-
lactams, aminoglycoside, macrolide, tetracycline, 
phenicol, quaternary amine, streptothricin, sulfonamide 
and diaminopyrimidine antimicrobial compounds. Apart 
from that, they also found that many of the resistance 
determinants were found in potentially mobile gene 
cassettes (Taitt et al., 2014).  
A. baumannii can cause life-threatening nosocomial 
infections in animals and humans and can limit the 
treatment options in intensive cares and routine 
procedures (Francey et al., 2000). Thus, the study showed 
that surfaces of inanimate objects can be a source of MDR 
A. baumannii in veterinary health care facilities that is of 
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